RxDoctor Payments Data

Scott Fridkin

Infectious Disease · Atlanta, GANPI 1073524849

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $400 of the $400 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, BD. That places this record below the midpoint for infectious disease clinicians in GA, where the typical reported total is $922.

$400in general payments, 2019–2025

Across 1 payment — averaging $400.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$400
$773,613in research payments, 2019–2025

Across 5 payments — averaging $154,723 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$774K

What the payments were for

  • Consulting fees$400100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD1$400

How this compares

$400 in reported general payments places this provider in the 40th percentile of 260 infectious disease providers in Georgia.

See all infectious disease providers in Georgia

Other infectious disease in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →